Lingye FAN, Ping ZHAN, Chunyan WANG, et al. Characteristics of HPV infection among 4 084 gynecological outpatients[J]. Journal of Army Medical University, 2023, 45(4): 335-342.
DOI:
Lingye FAN, Ping ZHAN, Chunyan WANG, et al. Characteristics of HPV infection among 4 084 gynecological outpatients[J]. Journal of Army Medical University, 2023, 45(4): 335-342. DOI: 10.16016/j.2097-0927.202206015.
Characteristics of HPV infection among 4 084 gynecological outpatients
To investigate the distribution of human papillomavirus (HPV) subtypes in women with different age and analyze the relationship between HPV and cervical lesions.
Methods
2
A cross-sectional study was conducted on 4 084 patients who underwent colposcopy for pathological examination and HPV genotyping assay in our hospital from January 2015 to June 2020. The patients are classified into 5 groups in respect to the age and 6 groups (the cervicitis
CIN Ⅰ
CIN Ⅱ
CIN Ⅲ
cervical carcinoma
in situ
and cervical cancer groups) in respect to pathological results respectively.
Chi
-square test was used to analyze the difference among groups mentioned and to analyze the overall situation of HPV infection
the positive rate of detection of HPV
subtype distribution
infection with single and multiple HPV genotypes among different age groups. Spearman's correlation analysis was used to analyze distribution characteristics of HPV subtypes infection and cervical lesion among different age groups.
Results
2
The positive rate of HPV was 93.24% (3808/4 084) different in 5 age groups(
Chi
-square=11.400
P
=0.022). The single subtype infection accounted for 64.67%
and the difference of single subtype infection and multiple subtypes infection was statistically significant among different age groups(
Chi
-square=70.736
P
<
0.001). HPV16(31.88%)、HPV52(25.20%)、HPV58 (14.57%)、HPV18 (11.12%)and HPV51(7.81%)were the top 5 among 23 subtypes of HPV detected. The distribution difference of positive rate of HPV was statistically significant among different lesion groups (
P
<
0.05). In the cervical cancer group
most patients were infected with HPV16
HPV 18
HPV 52
HPV 58
and HPV 33. Spearman's correlation analysis showed there was a significant co
rrelation between age and cervical lesions (
r
=0.051
P
=0.001). Positive rate of cervical cancer were 0.29% in age 18~29
1.08% in 30~39
3.52% in age 40~49
4.09% in age 50~59 and 10.37% in age 60~82.
Conclusion
2
HPV16
HPV 52
HPV 58 and HPV 18 are the most prevalent subtypes among 4 084 patients. HPV16 and HPV18 are relevant with cervical cancer. The risk of cervical cancer is significantly higher for women older than 40. The positive rate of cervical cancer increases with the age.
关键词
Keywords
references
FERLAY J, ERVIK M, LAM F, et al . Global cancer observatory: cancer today. [2022-03-01 ] . https://gco.iarc.fr/today https://gco.iarc.fr/today ..
World Health Organization. Human papillomavirus (HPV) and cervical cancer. [2020-5-18 ] . https://www.who.int/news-room/fact-sheets/detail/cervical-cancer https://www.who.int/news-room/fact-sheets/detail/cervical-cancer .
SMALL W Jr, BACON M A, BAJAJ A, et al . Cervical cancer: a global health crisis[J ] . Cancer, 2017, 123(13): 2404-2412. DOI: 10.1002/cncr.30667.
HARARI A, CHEN Z G, BURK R D. Human papillomavirus genomics: past, present and future[J]. Curr Probl Dermatol, 2014, 45: 1-18. DOI: 10.1159/000355952.
HU Z, MA D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications[J]. Cancer Med, 2018, 7(10): 5217-5236. DOI: 10.1002/cam4.1501.
BHATLA N, SINGHAL S. Primary HPV screening for cervical cancer[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 65: 98-108. DOI: 10.1016/j.bpobgyn.2020.02.008.
SAWAYAG F, SMITH-MCCUNE K, KUPPERMANN M. Cervical cancer screening: more choices in 2019[J]. JAMA, 2019, 321(20): 2018-2019. DOI: 10.1001/jama.2019.4595.
KARAD M, LEPE J S, PLANI A, et al . Distribution of human papillomavirus genotypes in women with high-grade cervical intraepithelial lesions and cervical carcinoma and analysis of human papillomavirus-16 genomic variants[J ] . Croat Med J, 2021, 62(1): 68-79. DOI: 10.3325/cmj.2021.62.68.
GUTNIK H, KASTELIC P, OŠTRBENK VALEN A, et al . Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorph ologic features[J ] . Virchows Arch, 2020, 476(2): 251-260. DOI: 10.1007/s00428-019-02694-7.
HASHIM D, ENGESÆTER B, BAADSTRAND SKARE G, et al . Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening[J ] . Br J Cancer, 2020, 122(11): 1715-1723. DOI: 10.1038/s41416-020-0790-1.
WEI B J, LI X X, QI J. Detection of human genotype Papilloma virus infection in 13 452 cases[J ] . Labeled Immunoass Clin Med, 2013, 20(3): 169-171. DOI: 10.11748/b jmy.issn.1006-1703.2013.03.015.
SCHIFFMAN M, SOLOMON D. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologiccotesting[J]. N Engl J Med, 2013, 369(24): 2324-2331. DOI: 10.1056/NEJMcp1210379.
CURRY S J, KRIST A H, OWENS D K, et al . Screening for cervical cancer: us preventive services task force recommendation statement[J ] . JAMA, 2018, 320(7): 674-686. DOI: 10.1001/jama.2018.10897.
SASLOW D, SOLOMON D, LAWSON H W, et al . American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J ] . J Low Genit Tract Dis, 2012, 16(3): 175-204. DOI: 10.1097/LGT.0b013e31824ca9d5.
MA H P, JIAO X, ZHAO Y H, et al . Screening and genotype analysis of human Papilloma virus in Tengzhou area of Shandong Province[J ] . Chin J Clin Infect Dis, 2021(3): 203-207. DOI: 10.3760/cma.j.issn.1674-2397.2021.03.008..
HUH W K, AULT K A, CHELMOW D, et al . Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance[J ] . J Low Genit Tract Dis, 2015, 19(2): 91-96. DOI: 10.1097/LGT.0000000000000103.
LI M X, DU XX, LU M H, et al . Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China[J ] . J Med Virol, 2019, 91(3): 473-481. DOI: 10.1002/jmv.25331.
CHEN L, DONG Y, LI J, et al . The genomic distribution map of human papillomavirus in western China[J ] . Epidemiol Infect, 2021, 149: e135. DOI: 10.1017/S0950268821001175.
TAN S C, ISMAIL M P, DUSKI D R, et al . Prevalence and type distribution of human papillomavirus (HPV) in Malaysian women with and without cervical cancer: an updated estimate[J ] . Biosci Rep, 2018, 38(2): BSR20171268. DOI: 10.1042/BSR20171268.
ZENG Z Y, YANG H T, LI Z B, et al . Prevalence and genotype distribution of HPVinfection in China: analysis of 51 345 HPV genotyping results from China's largest CAP certified laboratory[J ] . J Cancer, 2016, 7(9): 1037-1043. DOI: 10.7150/jca.14971.
ZHOU C, CHAI Y M, CHEN R, et al . Study on human papillomavirus infection and genotyping of 2 698 women in Jingmen[J ] . Shanxi Med J, 2020, 49(11): 1523-1526. DOI: 10.3969/j.issn.1000-7377.2020.11.040.
DU H Y, XIAO M M. Analysis of cervical papillomavirus infection and its genotype in 6 590 gynecological outpatients in an area[J]. Med J Chin People Heal, 2020, 32(1): 127-128, 131. DOI: 10.3969/j.issn.1672-0369.2020.01.051.
ZHANG J Y, CHENG K Y, WANG Z L. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis[J]. Arch Gynecol Obstet, 2020, 302(6): 1329-1337. DOI: 10.1007/s00404-020-05787-w.
Construction and validation of prediction model for cervical cancer recurrence based on systemic inflammation response index and clinicopathological parameters
Feasibility of repeated using 3D printed applicator in brachytherapy for cervical cancer
Effect of RNA sensor IFIH1 on proliferation, migration and invasion of HPV positive cervical cancer cells
Safety of ultra-early postoperative activity after laparoscopic radical hysterectomy for cervical cancer
Features of HPV infection and screening characteristics of high-risk HPV negative in patients with cervical high-grade squamous intraepithelial lesion: a retrospective analysis of 459 cases
Related Author
GUAN Tinghong
GONG Chunxia
TU Yuan
TIAN Chenfan
YU Jiaxin
JIANG Peng
Xiujuan ZHAO
Mingsong ZHONG
Related Institution
Department of Gynecology and Obstetrics, the First Affiliated Hospital of Chongqing Medical University
Department of Gynecology and Obstetrics, Women and Children’s Hospital Affiliated to Chongqing Medical University
Gynecological Oncology Center, Chongqing University Cancer Hospital
Treatment Center of Radiation Oncology, Chongqing University Cancer Hospital
Institute of Life Sciences, Chongqing Medical University